Overview
- 46 inspections across 46 sites are on record.
- 121 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-15.
At a glance
Inspections
46
Sites
46
Observations
121
Career since
Jun 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Genentech, Inc. | 15 May 2026 | Human Drugs | |
| Silgan Unicep Packaging, LLC | 2 Apr 2026 | Human Drugs | View 483 → |
| K.C. Pharmaceuticals, Inc | 13 Feb 2026 | Human Drugs | On file |
| Hunan Xiangyikang Pharmaceutical Co., Ltd. | 21 Nov 2025 | Human Drugs | On file |
| Hunan Warrant Chiral Pharmaceutical Co., Ltd. | 14 Nov 2025 | Human Drugs | On file |
Sites inspected
Genentech, Inc.South San Francisco, United States1 insp.
Silgan Unicep Packaging, LLCSpokane, United States1 insp.
K.C. Pharmaceuticals, IncPomona, United States1 insp.
Hunan Xiangyikang Pharmaceutical Co., Ltd.Yiyang, China1 insp.
Hunan Warrant Chiral Pharmaceutical Co., Ltd.Changsha, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Pearl C Ozuruigbo5 shared
Gavin T Cua5 shared
Carolina D Vasquez4 shared
Youkeun Kim4 shared
Joey V Quitania3 shared
Lillian S Wu3 shared
Taichun Qin3 shared
Ngozi G Offor2 shared
Nathan E Hellman2 shared
Walden H Lee2 shared
Full investigator report
Get the verbatim findings behind Crystal Monroy's 121 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site